Your browser doesn't support javascript.
loading
An observational study to understand burden and cost of care in adults diagnosed with refractory chronic cough (RCC) or unexplained chronic cough (UCC).
Smith, Jaclyn A; Stein, Norman; Migas, Sylwia; Bokowski, Sue; Williams, Claire; Baker, Patricia; New, John; Schelfhout, Jonathan; Fonseca, Eileen; Langerman, Haya.
Afiliação
  • Smith JA; Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK. jacky.smith@manchester.ac.uk.
  • Stein N; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Education and Research Centre, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK. jacky.smith@manchester.ac.uk.
  • Migas S; NorthWest Ehealth Ltd, Manchester Science Park, Manchester, UK.
  • Bokowski S; NorthWest Ehealth Ltd, Manchester Science Park, Manchester, UK.
  • Williams C; NorthWest Ehealth Ltd, Manchester Science Park, Manchester, UK.
  • Baker P; NorthWest Ehealth Ltd, Manchester Science Park, Manchester, UK.
  • New J; NorthWest Ehealth Ltd, Manchester Science Park, Manchester, UK.
  • Schelfhout J; Salford Royal NHS Foundation Trust, Salford, UK.
  • Fonseca E; Merck & Co., Inc., Rahway, NJ, USA.
  • Langerman H; Merck & Co., Inc., Rahway, NJ, USA.
Respir Res ; 25(1): 265, 2024 Jul 04.
Article em En | MEDLINE | ID: mdl-38965601
ABSTRACT

BACKGROUND:

Refractory and unexplained chronic cough (RCC and UCC) necessitate frequent referral for specialist evaluations, but data on healthcare resource utilisation and costs are lacking.

METHODS:

This observational study enrolled adults with RCC or UCC attending a specialist cough clinic and included a control cohort, both from North West England, matched 15 for age, gender and smoking history. Primary and secondary care data were obtained for the 5 years prior to and 2 years post initial clinic visit (index). The primary endpoint was the total 5-year healthcare cost to the UK NHS pre-RCC or UCC diagnosis compared to the control cohort.

RESULTS:

Mean age at index for the 200 RCC or UCC consented patients was 62.2 ± 11.4 years; 71% were female, and 68% had never smoked. Mean duration of symptoms pre-diagnosis was 8.0 ± 9.4 years. Mean cough severity score was 63.7 ± 23.2 mm at index on a Visual Analog Scale, and Leicester Cough Questionnaire total score was 10.9 ± 4.1. GP data were available for 80 patients and mean total cost over the 5 years pre-diagnosis (index date) was 3.0-fold higher (95% CI 2.3, 3.9) than in the control cohort (p < 0.001). Most excess costs were related to visits and procedures carried out in secondary care. RCC- or UCC-associated costs decreased post-diagnosis, but remained higher than those of controls.

CONCLUSION:

Diagnosis of RCC or UCC requires significant health resource utilisation in the 5 years prior to a specialist clinic diagnosis. Resource utilisation was less after diagnosis, but remained higher than in a matched control cohort.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Cuidados de Saúde / Tosse Limite: Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Cuidados de Saúde / Tosse Limite: Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article